SOHO State of the Art Updates and Next Questions|Elderly Acute Lymphoblastic Leukemia: Low-dose chemotherapy and
Perrine Moyer1, Aude-Marie Fourmont1, Lucie Freiman2
1Hematology Department, Nantes University Hospital, Nantes, France.
Clinical Lymphoma, Myeloma & Leukemia
|June 27, 2025
Summary
Elderly patients with acute lymphoblastic leukemia (ALL) have limited treatment options. Novel therapies, including chemo-free approaches and new drugs, show promising results for improving survival in these patients.
Area of Science:
- Hematology
- Oncology
- Geriatric Medicine
Background:
- Acute lymphoblastic leukemia (ALL) presents a significant challenge in elderly patients, with current chemotherapy yielding suboptimal long-term survival rates.
- There is a critical unmet medical need for effective ALL treatments tailored to the geriatric population.
Purpose of the Study:
- To review recent advancements in the management of acute lymphoblastic leukemia in elderly patients.
- To explore current therapeutic strategies and future directions, incorporating novel agents into front-line treatments.
Main Methods:
- Sequential consideration of Philadelphia chromosome (Ph)-negative ALL, Ph-positive ALL, and T-cell ALL (T-ALL) in elderly populations.
- Discussion of novel therapeutic strategies, including chemo-free approaches and targeted agents.
Main Results:
- Emerging novel agents developed for refractory/relapsed ALL are demonstrating very promising results when integrated into front-line therapies.
- Specific novel agents discussed include inotuzumab ozogamicin, blinatumomab, venetoclax, tyrosine kinase inhibitors, and CAR T-cells.
Conclusions:
- Novel therapeutic strategies and agents offer significant promise for improving outcomes in elderly patients with ALL.
- The integration of these new treatments represents a paradigm shift in managing acute lymphoblastic leukemia in this vulnerable patient group.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:27Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:22Bone Marrow Sampling and Transplants
506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506